-
公开(公告)号：US07381406B2
公开(公告)日：2008-06-03
申请号：US10934236
申请日：2004-09-02
申请人： Ralf Zink , Roberto Reniero , Florence Rochat , Christoph Cavadini , Thierry Von Der Weid , Eduardo Schiffrin , Jalil Benyacoub , Virginie Rousseau , Pablo Perez , Ruth Knorr
发明人： Ralf Zink , Roberto Reniero , Florence Rochat , Christoph Cavadini , Thierry Von Der Weid , Eduardo Schiffrin , Jalil Benyacoub , Virginie Rousseau , Pablo Perez , Ruth Knorr
CPC分类号： C12R1/225 , A23K10/18 , A23K50/42 , A23K50/48 , A61K35/744 , A61K35/745 , A61K35/747 , C12R1/23 , C12R1/46 , Y10S426/805
摘要： The present invention provides novel strains of probiotics for use in the gastrointestinal tract of a pet. The probiotics of the present invention are capable of fermenting starch to produce lactic acid and/or hydrogen peroxide anti-pathogenic metabolites. The present invention also provides a novel method for identifying the effectiveness of a pet probiotic in vitro. The method simulates the introduction of a probiotic candidate in the gastrointestinal tract of a pet and measures the anti-pathogenic effectiveness of the probiotic.
摘要翻译： 本发明提供用于宠物胃肠道中的益生菌的新菌株。 本发明的益生菌能够发酵淀粉以产生乳酸和/或过氧化氢抗病原代谢物。 本发明还提供了一种用于鉴定宠物益生菌在体外的有效性的新方法。 该方法模拟在宠物的胃肠道中引入益生菌候选物并测量益生菌的抗病原效力。
-
公开(公告)号：US08771675B2
公开(公告)日：2014-07-08
申请号：US12053037
申请日：2008-03-21
申请人： Ralf Zink , Roberto Reniero , Florence Rochat , Christoph Cavadini , Thierry Von Der Weid , Eduardo Schiffrin , Jalil Benyacoub , Virginie Rousseau , Pablo Perez , Ruth Knorr
发明人： Ralf Zink , Roberto Reniero , Florence Rochat , Christoph Cavadini , Thierry Von Der Weid , Eduardo Schiffrin , Jalil Benyacoub , Virginie Rousseau , Pablo Perez , Ruth Knorr
CPC分类号： C12R1/225 , A23K10/18 , A23K50/42 , A23K50/48 , A61K35/744 , A61K35/745 , A61K35/747 , C12R1/23 , C12R1/46 , Y10S426/805
摘要： The present invention provides novel strains of probiotics for use in the gastrointestinal tract of a pet. The probiotics of the present invention are capable of fermenting starch to produce lactic acid and/or hydrogen peroxide anti-pathogenic metabolites. The present invention also provides a novel method for identifying the effectiveness of a pet probiotic in vitro. The method simulates the introduction of a probiotic candidate in the gastrointestinal tract of a pet and measures the anti-pathogenic effectiveness of the probiotic.
摘要翻译： 本发明提供用于宠物胃肠道中的益生菌的新菌株。 本发明的益生菌能够发酵淀粉以产生乳酸和/或过氧化氢抗病原代谢物。 本发明还提供了一种用于鉴定宠物益生菌在体外的有效性的新方法。 该方法模拟在宠物的胃肠道中引入益生菌候选物并测量益生菌的抗病原效力。
-
公开(公告)号：US20080171106A1
公开(公告)日：2008-07-17
申请号：US12053037
申请日：2008-03-21
申请人： Ralf Zink , Roberto Reniero , Florence Rochat , Christoph Cavadini , Thierry Von Der Weid , Eduardo Schiffrin , Jalil Benyacoub , Virginie Rousseau , Pablo Perez , Ruth Knorr
发明人： Ralf Zink , Roberto Reniero , Florence Rochat , Christoph Cavadini , Thierry Von Der Weid , Eduardo Schiffrin , Jalil Benyacoub , Virginie Rousseau , Pablo Perez , Ruth Knorr
IPC分类号： A23K1/00
CPC分类号： C12R1/225 , A23K10/18 , A23K50/42 , A23K50/48 , A61K35/744 , A61K35/745 , A61K35/747 , C12R1/23 , C12R1/46 , Y10S426/805
摘要： The present invention provides novel strains of probiotics for use in the gastrointestinal tract of a pet. The probiotics of the present invention are capable of fermenting starch to produce lactic acid and/or hydrogen peroxide anti-pathogenic metabolites. The present invention also provides a novel method for identifying the effectiveness of a pet probiotic in vitro. The method simulates the introduction of a probiotic candidate in the gastrointestinal tract of a pet and measures the anti-pathogenic effectiveness of the probiotic.
摘要翻译： 本发明提供用于宠物胃肠道中的益生菌的新菌株。 本发明的益生菌能够发酵淀粉以产生乳酸和/或过氧化氢抗病原代谢物。 本发明还提供了一种用于鉴定宠物益生菌在体外的有效性的新方法。 该方法模拟在宠物的胃肠道中引入益生菌候选物并测量益生菌的抗病原效力。
-
公开(公告)号：US20070098744A1
公开(公告)日：2007-05-03
申请号：US11544120
申请日：2006-10-06
IPC分类号： A61K39/02
CPC分类号： C12R1/01 , A23K10/18 , A23K20/168 , A23K20/184 , A23K50/40 , A23K50/48 , A23L33/135 , A61K31/5685 , A61K35/744 , A61K39/12 , A61K39/125 , A61K39/23 , A61K39/245 , A61K2039/552 , A61K2039/55511 , A61K2039/70 , C12N7/00 , C12N2710/16034 , C12N2750/14034 , C12N2770/16034 , C12R1/46
摘要： Compositions and methods for modulating immunity and vaccine efficacy in animals are disclosed. The compositions and methods utilize probiotic organisms, specifically probiotic Enterococcus strains, and are particularly applicable to felines.
摘要翻译： 公开了调节动物免疫力和疫苗功效的组合物和方法。 组合物和方法利用益生菌，特别是益生菌肠球菌菌株，特别适用于猫科动物。
-
5.发明申请Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis 审中-公开用于调节免疫力，增强疫苗功效，减少与慢性FHV-1感染相关的发病率以及预防或治疗结膜炎的组合物和方法公开(公告)号：US20070280964A1
公开(公告)日：2007-12-06
申请号：US11805813
申请日：2007-05-24
CPC分类号： A61K39/245 , A23K10/18 , A23K50/48 , A61K39/12 , A61K39/125 , A61K39/23 , A61K2039/5254 , A61K2039/54 , A61K2039/552 , A61K2039/55511 , A61K2039/70 , C12N2710/16034 , C12N2750/14034 , C12N2770/16034
摘要： Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and/or preventing or treating conjunctivitis in animals. The compositions contain effective amounts of probiotic Enterococcus bacteria and the methods involve administering such compositions to animals alone, in supplements, or in food compositions in amounts suitable for the intended purpose. In certain embodiments, the probiotic is Enterococcus faecium strain NCIMB 10415 (SF68) and the animal is a feline.
摘要翻译： 用于调节免疫力，增强疫苗功效，降低与慢性FHV-1感染相关的发病率和/或预防或治疗动物结膜炎的组合物和方法。 所述组合物含有有效量的益生菌肠球菌，并且所述方法包括将这些组合物单独施用于动物，补充剂或食物组合物中，适用于预期目的的量。 在某些实施方案中，益生菌是屎肠球菌菌株NCIMB 10415（SF68），动物是猫科动物。
-
-
-
-
搜索结果
5 条记录 (耗时 0.046 秒)
